Table 1 Clinical and biochemical features of patients with acute myocardial infarction and controls
Patients (n= 108) | Controls (n =81) | P | |
|---|---|---|---|
Age (years) | 63 ± 12 | 59 ± 9 | NS |
Men (%) | 70 | 38 | |
BMI (kg/m 2 ) | 27 ± 6 | 23 ± 3 | NS |
Diabetes mellitus (%) | 61 | 0 | |
Dyslipidemia (%) | 45 | 0 | |
Hypertension (%) | 70 | 0 | |
Smokers (%) | 50 | 6 | |
Alcohol (%) | 25 | 0 | |
Apo A1 (g/L) | 1.26 ± 0.19 | 1.5 ± 0.17 | <0.001 |
Apo B (g/L) | 1.29 ± 0.36 | 0.92 ± 0.22 | <0.001 |
TAS (mmol/L) | 1.47 ± 0.38 | 1.71 ± 0.22 | <0.001 |
Catalase (kU/g Hb) | 283 ± 141 | 652 ± 104 | <0.001 |
Homocysteine (μmol/L) | 26.9 ± 15.47 | 14.75 ± 2.69 | <0.001 |
TBARS (μmol/L) | 1.31 ± 0.36 | 0.71 ± 0.12 | <0.001 |
Troponine TnIc (μg/L) | 5,04 ± 2,90 | 0 | |
Q wave AMI | 9,13 ± 2,18 | ||
Non Q wave AMI | 4,09 ± 2,03 | ||
Treatment | |||
Statins (%) | 38 | 0 | |
Beta-Blockers (%) | 40 | 0 | |
Ca-Blockers (%) | 28 | 0 | |
Diuretics (%) | 37 | 0 |